PFIZER offshoot Hospira has confirmed a voluntary recall in the US of 47 lots of sodium bicarbonate injection and other injectables to the hospital/retail level, upon fears of microbial contamination.
The FDA has allowed the vetted Australian drugmaker Phebra to export NaHCO3 vials to the US to help alleviate the shortage, but at more than 10 times the cost, according to Modern Healthcare.
The above article was sent to subscribers in Pharmacy Daily's issue from 20 Jun 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 20 Jun 17